Australian Clinical Labs Limited (ASX:ACL)
Australia
· Delayed Price · Currency is AUD 1.930
-0.015 (-0.77%)
Apr 28, 2026, 4:10 PM AEST
Australian Clinical Labs Market Cap
Australian Clinical Labs has a market cap or net worth of 360.28 million as of April 28, 2026. Its market cap has decreased by -38.46% in one year.
Market Cap
360.28M
Enterprise Value
652.73M
Revenue
737.49M
Ranking
n/a
PE Ratio
13.69
Stock Price
1.93
Market Cap Chart
Since May 14, 2021, Australian Clinical Labs's market cap has decreased from 690.27M to 360.28M, a decrease of -47.81%. That is a compound annual growth rate of -12.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 362.15M | -31.01% |
| Dec 31, 2025 | 524.97M | -23.31% |
| Dec 31, 2024 | 684.50M | 18.13% |
| Dec 29, 2023 | 579.45M | -3.17% |
| Dec 30, 2022 | 598.41M | -52.18% |
| Dec 31, 2021 | 1.25B | 81.29% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Healius | 384.85M |
| Monash IVF Group | 284.43M |
| Integral Diagnostics | 830.65M |
| Rhythm Biosciences | 61.93M |
| Cryosite | 51.25M |
| INOVIQ | 46.46M |
| Microba Life Sciences | 43.85M |
| Genetic Signatures | 32.94M |